Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Farah Champsi currently holds 11,538 shares of NeurogesX Inc (NGSX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Farah Champsi has been a net seller of NGSX stock. They have purchased $3.4M and sold $71.5M worth of shares.
Farah Champsi's most recent insider trade was on Jan 22, 2020, when they sold 11,538 shares at $0.00 per share.
Farah Champsi serves as Executive at NeurogesX Inc (NGSX). They have executed 48 insider transactions totaling $74.9M over their tenure at the company.
Farah Champsi holds the position of Executive at NeurogesX Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Farah Champsi has shown a selling trading pattern, with $3.4M in total purchases and $71.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Farah Champsi was on Jun 30, 2015, when they sold $22.6M worth of KITE shares. This transaction involved 358,757 shares at $63.01 per share.
Farah Champsi currently owns 11,538 shares of NeurogesX Inc (NGSX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Farah Champsi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Farah Champsi has 48 Form 4 filings on record as an insider at NeurogesX Inc.
Set alerts for Farah Champsi and 40,000+ other insiders.